Because of delayed child bearing, unhealthy diets and use of tobacco, caffeine, alcohol, drugs and environmental contaminants, difficulties in conceiving have been experienced.
Needs exist for pharmaceutical compounds that improve fertility in both women and men.
This invention provides combinations of bioeffecting compounds for promoting fertility in men and women. The combinations include nutritional components that benefit fertility health. All the components have been studied separately, to determine their individual efficacy. The invention provides the first products to put these components together synergistically in women's and men's formulations.
As many as 15% of couples in the U.S. have difficulty conceiving a child. In about one third of these cases, it is the man that is infertile; in another third, the female has fertility issues. The remaining is due to a combination of male and female fertility issues, or unknown causes. In many of these cases, causes of infertility are treatable. Nutritional and lifestyle changes should be the first step to increasing chances for conception. Smoking and caffeine, drug and alcohol consumption, environmental toxicants, and stress are related to infertility in men and women. Reproductive organs are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. A balanced, nutritional diet, and nutritional supplements with high antioxidant content can help reverse some of that damage. In women, hormone balance is critical to monthly ovulation and development of the corpus luteum (an ovarian follicle that release progesterone after release of the egg to prepare the uterus for implantation).
These and further and other objects and features of the invention are apparent in the disclosure, which include the above ongoing written specification with the claims.
The invention provides combinations of beneficial bioeffecting compounds for promoting fertility in women. The invention provides a scientifically validated herbal/nutritional blend for women to improve infertility by helping to regulate the menstrual cycle and correct hormone imbalance (corpus luteum insufficiency) without increased chances of multiple births associated with drug therapy. The combination of amino acids, herbs, vitamins and minerals improves overall health and helps with many of the deficiencies that decrease fertility.
The herb, Vitex agnus-castus (chasteberry), enhances hormone balance by increasing progesterone release and, therefore, ovulation frequency. The antioxidants, green tea, vitamin E, and selenium, improve overall reproductive health. L-arginine, an amino acid, stimulates the reproductive organs by improving circulation. Folic acid, vitamins B6 and B12, iron, zinc and magnesium help promote womens' fertility.
The invention provides combinations of beneficial bioeffecting compounds for promoting fertility in men. Sperms are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. Vitamins C and E, coenzyme Q10 and selenium are all potent antioxidants that help improve sperm counts and quality. Ferulic acid, an antioxidant found in Dong quai, also improves sperm quality. Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motility. The amino acid, L-carnitine, promotes formation of healthy sperm.
The invention provides synergistic action of the combinations.
The two dietary supplements in male and female formulas are useful for men and women. Preferably, the distinct combinations are taken by both members of a couple in which the female age is between 21 and 46. The distinct combinations are useful for couples who have tried for 6 months or more, up to three years, to become pregnant without success. Preferably, patients take 2-4 capsules per day of the distinct formulas for three months. In women it is useful to record their basal temperature daily using thermometers and charts and to have their blood drawn for progesterone analysis at day 18-22 of the first menstrual cycle prior to taking the supplement. For men, it is useful to submit a sperm sample at the same time for analysis of count and motility. Prior to submitting sperm samples, 2-4 days abstinence is suggested for best results. No fevers over 101 degrees in the three months prior to taking the new combinations should be encountered. It is useful to repeat the analyses during the fourth menstrual cycle of the study. The first month is needed to develop baselines, followed by three months of taking the combinations product or placebo.
Preferred ranges of the combinations considered in percent by weight are:
Acceptable ranges of womens' and mens' formulations are:
Examples of useful formulations in percent by weight are:
While the invention has been described with references to specific embodiments, modifications and variations of the invention may be constructed without departing from the scope of the invention, which is defined in the following claims.
This application is a divisional of application Ser. No. 09/742,412 filed Dec. 22, 2000 now U.S. Pat. Nos. 6,497,885.
Number | Name | Date | Kind |
---|---|---|---|
2878124 | Kruckenberg | Mar 1959 | A |
3015567 | Hause et al. | Jan 1962 | A |
3360374 | Barr et al. | Dec 1967 | A |
3970750 | Brockemeyer et al. | Jul 1976 | A |
4154813 | Kleinberg | May 1979 | A |
4168307 | Okamoto et al. | Sep 1979 | A |
4340592 | Adibi | Jul 1982 | A |
4388325 | Orzalesi | Jun 1983 | A |
4599232 | Bertelli | Jul 1986 | A |
4900566 | Howard | Feb 1990 | A |
4920098 | Cotter et al. | Apr 1990 | A |
4954526 | Keefer | Sep 1990 | A |
4957938 | Anderson et al. | Sep 1990 | A |
5032608 | Dudrick | Jul 1991 | A |
5034377 | Adibi et al. | Jul 1991 | A |
5036052 | Ozeki et al. | Jul 1991 | A |
5041429 | Sawai et al. | Aug 1991 | A |
5106836 | Clemens et al. | Apr 1992 | A |
5157022 | Barbul | Oct 1992 | A |
5171217 | March et al. | Dec 1992 | A |
5217997 | Levere et al. | Jun 1993 | A |
5221668 | Henningfield et al. | Jun 1993 | A |
5248688 | Dudrick | Sep 1993 | A |
5262435 | Joshua et al. | Nov 1993 | A |
5278189 | Rath et al. | Jan 1994 | A |
5288490 | Budzynski et al. | Feb 1994 | A |
5296246 | Inoue et al. | Mar 1994 | A |
5326569 | Acosta et al. | Jul 1994 | A |
5334617 | Ulrich et al. | Aug 1994 | A |
5364644 | Walaszek et al. | Nov 1994 | A |
5374651 | Kilbourn et al. | Dec 1994 | A |
5380945 | Murad et al. | Jan 1995 | A |
5385937 | Stamler et al. | Jan 1995 | A |
5385940 | Moskowitz | Jan 1995 | A |
5411956 | Miyazaki et al. | May 1995 | A |
5428070 | Cooke et al. | Jun 1995 | A |
5439938 | Snyder et al. | Aug 1995 | A |
5464644 | Wullschleger et al. | Nov 1995 | A |
5500266 | Durnin | Mar 1996 | A |
5523087 | Shlyankevich | Jun 1996 | A |
5543430 | Kaesemeyer | Aug 1996 | A |
5545414 | Behr et al. | Aug 1996 | A |
5576287 | Zaloga et al. | Nov 1996 | A |
5576351 | Yoshimura et al. | Nov 1996 | A |
5594032 | Gonzalez-Cadavid et al. | Jan 1997 | A |
5626883 | Paul | May 1997 | A |
5631031 | Meade | May 1997 | A |
5650418 | Rath et al. | Jul 1997 | A |
5730987 | Omar | Mar 1998 | A |
5767160 | Kaesemeyer | Jun 1998 | A |
5780039 | Greenberg et al. | Jul 1998 | A |
5852058 | Cooke et al. | Dec 1998 | A |
5861168 | Cooke et al. | Jan 1999 | A |
5883086 | Craft | Mar 1999 | A |
5891459 | Cooke et al. | Apr 1999 | A |
5897864 | Cohen | Apr 1999 | A |
5945452 | Cooke et al. | Aug 1999 | A |
6007824 | Duckett et al. | Dec 1999 | A |
6117872 | Maxwell et al. | Sep 2000 | A |
6156802 | Mae et al. | Dec 2000 | A |
Number | Date | Country |
---|---|---|
441119 | Aug 1991 | EP |
511587 | Apr 1992 | EP |
511118 | Oct 1992 | EP |
0546796 | Jun 1993 | EP |
50 48189 | Apr 1975 | JP |
57 5692 | Jan 1982 | JP |
57 93913 | Jun 1982 | JP |
58-55418 | Apr 1983 | JP |
05-163139 | Jun 1993 | JP |
06-321786 | Nov 1994 | JP |
07 163269 | Jun 1995 | JP |
WO93 18156 | Sep 1993 | WO |
WO9401006 | Jan 1994 | WO |
94 10015 | Sep 1993 | ZA |
Number | Date | Country | |
---|---|---|---|
20030026851 A1 | Feb 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09742412 | Dec 2000 | US |
Child | 10252698 | US |